Abstract
Presentation Description :
Transitioning medical products from the research and development community, through Food and Drug Administration (FDA), and into the battlefield presents many regulatory, operational testing, logistical, and sustainability considerations. Ensuring that solutions are both operationally effective and suitable can present challenges for military users. These issues will be presented and solutions will be discussed with the audience.
This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.